Table 2 Diagnosis of comorbidities in patients with IPF
From: Clinical and economic burden of idiopathic pulmonary fibrosis: a retrospective cohort study
2009 | 2010 | 2011 | |
|---|---|---|---|
(N = 1191) | (N = 1292) | (N = 1136) | |
CCI, mean (SD) | 3.2 (2.7) | 3.2 (2.7) | 3.2 (2.7) |
Number of chronic conditions, mean (SD) | 5.9 (2.0) | 5.9 (2.0) | 5.9 (2.0) |
Conditions, n (%) | |||
COPD (including emphysema) | 636 (53.4) | 692 (53.6) | 646 (56.9) |
Cardiovascular conditions | 573 (48.1) | 626 (48.5) | 581 (51.1) |
Bacterial pneumonia | 364 (30.6) | 380 (29.4) | 351 (30.9) |
Lung cancer | 49 (4.1) | 39 (3.0) | 43 (3.8) |
Pulmonary hypertension | 101 (8.5) | 131 (10.1) | 79 (7.0) |
GERD | 332 (27.9) | 378 (29.3) | 336 (29.6) |
Obstructive sleep apnea | 176 (14.8) | 199 (15.4) | 169 (14.9) |
Obesity | 95 (8.0) | 106 (8.2) | 87 (7.7) |